I was a ‘fat mum' so jabbed Mounjaro & lost 11st – now I'm asking strangers to pay for surgery to fix my apron belly
A MUM says she "struggles to look at herself naked" after she was left with "saggy skin" when she lost 11st after using Mounjaro jabs.
Jade Stalker, 36, weighed 22st 8lbs at her heaviest, after decades of scoffing crisps,
4
After decades of scoffing Chinese takeaways and crisps, Jade, 36, topped the scales at 22st 8lbs
Credit: SWNS
4
After forking out for a gastric sleeve and going on Mounjaro, the mum now weighs 11st 8lbs
Credit: SWNS
4
Despite feeling 'fantastic', Jade says she's been left with an "overhang on my stomach" and "saggy" boobs due to excess skin
Credit: SWNS
4
She has since launched on online funding page seeking to raise £6,000 for surgery to remove excess
Credit: SWNS
Just before her daughter, now five, started nursery in May 2023, Jade was concerned she'd be seen as one of the 'fat mums' at the school gates - and made a bid to lose 10st.
After splashing out £3,500 on flights to Turkey and
Now 11st 8lbs, she says she's been left with
She has launched on online funding page seeking to raise £6,000 for surgery to remove excess asking from her stomach, breasts and inner thighs.
READ MORE ON DIETS
Jade, a telecommunications engineer from Sauchie, Scotland, said: 'My skin now is so loose, when I get in the bath, it ripples.
'I have quite a large overhang on my stomach - and my boobs are saggy, despite my doctors telling me they'd get smaller after losing all the weight.
'My partner loves me the way I am - she doesn't care about all that - but I think when you're in a relationship, you do want to look good for your partner.'
Jade, who wears men's clothes and started at a 58in waist, says she's never been bothered about her size.
Most read in Fabulous
She'd have four
But becoming a mum changed her view.
Watch Ellen's weight loss journey on fat jabs
Wanting to teach her daughter 'what a healthy body looks like' she booked flights and a gastric sleeve operation in
She could barely eat three-quarters of a burger, after the surgery and lost 5st 8lb in a year.
But said the operation hadn't done enough to cure her 'head hunger,' so began a course of Mounjaro via an online pharmacy in October 2024.
What to do if you lose too much weight too quickly whilst on Mounjaro
IF you're losing too much weight too quickly while on Mounjaro, it's important to take action to avoid potential health risks like muscle loss, malnutrition, dehydration, and fatigue. Here's what you can do:
Evaluate Your Caloric Intake
Mounjaro reduces appetite, which can make it easy to eat too little. If you're losing weight too fast (more than two to three lbs per week after the initial adjustment period), try:
Tracking your food intake to ensure you're eating enough calories (apps like MyFitnessPal can help).
Increasing protein intake to preserve muscle mass (aim for 0.6–1g per pound of body weight).
Adding healthy fats and complex carbs (e.g., avocados, nuts, whole grains) for balanced energy.
Adjust Your Dosage (With Doctor's Approval)
If your weight loss is too rapid or causing side effects, your doctor may:
Pause dose increases or lower your dosage.
Adjust your treatment plan to stabilise your weight loss.
Strength Training & Exercise
To prevent muscle loss:
Incorporate resistance training at least two to three times per week.
Stay active with low-impact exercises like walking or yoga.
Hydrate & Manage Electrolytes
Drink enough water (Mounjaro can reduce thirst).
Electrolytes matter - Consider adding magnesium, sodium, and potassium if you feel weak or fatigued.
Monitor for Malnutrition & Deficiencies
Rapid weight loss can cause vitamin/mineral deficiencies (especially B12, iron, and electrolytes). If you experience:
Fatigue, hair loss, or dizziness, ask your doctor about supplements.
Consider Further Medical Guidance
If your weight loss is excessive or causing health concerns, speak with your healthcare provider.
They might adjust your dosage, diet, or exercise plan to help stabilise your weight loss.
'The only thing that made me less mentally hungry was
"Being on it is like walking through Tesco when you've just had a huge meal.'
She lost a further 5st 2lb.
She noticed "saggy skin" early into her
She added: 'I'd say my most conscious areas are my stomach, my boobs and my inner thighs - although I'm quite a
'I've held off from doing a
Jade's meals before and now
Before weight loss:
Breakfast: Four ham rolls
Lunch: A Tesco meal deal, with an extra bag of crisps and a chocolate bar
Dinner: A Chinese takeaway, fish and chips, or 'man-sized' plate of spaghetti Bolognese with garlic bread
Snacks: Nuts, a late-night bag of sweets
After losing weight:
Breakfast: Two slices of toast, with butter
Lunch: Meal deal wrap, with yoghurt and a Ribena Light
Dinner: Halloumi wrap with salad inside
Snack: Light yoghurt.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Irish Sun
16 hours ago
- The Irish Sun
World Health Organisation admits they STILL have no idea what caused Covid pandemic – but refuses to rule out lab leak
A LEADING theory that the Covid pandemic originated from a lab leak in China cannot be ruled out, the World Health Organisation said. A Advertisement 7 China's Wuhan lab has been at the centre of the lab leak theory since Covid emerged just miles from the facility 7 Staff members line up at attention as they prepare to spray disinfectant at Wuhan Railway Station 7 Dr Shi Zhengli - dubbed 'Batwoman' for her research on bat coronaviruses - at the Wuhan Institute of Virology The Scientific Advisory Group for the Origins of Novel Pathogens (Sago) said on Friday that most data suggests the This is the same Watch the documentary in full on our YouTube channel Their new But they added: "Nor can it be proven until more information is provided." Advertisement Group chair Marietjie Venter said after three years of investigating, they were unable to come to a certain They blasted China for not releasing all necessary data to determine Covid's creation - despite hundreds of requests for genetic sequences and biosecurity information to the She Venter: "Therefore, this hypothesis could not be investigated or excluded. "It was deemed to be very speculative, based on political opinions and not backed up by science." Advertisement Most read in The US Sun Venter said the 27-member group could not reach a unanimous conclusion on Three other scientists also asked for their names to be removed from the new report. I was in Oval Office with Trump at start of pandemic - no one was closer to Chinese officials than me & I believe Covid was engineered in lab Covid-19 emerged just eight miles from the Wuhan Institute of Virology. Scientists there had been importing and manipulating bat coronaviruses and had been filmed handling animals with inadequate protection. Advertisement Venter added that there was no evidence proving Covid was created in a lab, nor was there any indication it was spreading before December 2019 anywhere outside of China. She said: "Until more scientific data becomes available, the origins of how SARS-CoV-2 entered human populations will remain inconclusive." Beijing has consistently refused to release full details about the lab in Wuhan, despite repeated requests for information from multiple countries. 7 A woman wearing a face mask holds a baby that wears a protective shield in Wuhan Advertisement 7 The P4 laboratory at the Wuhan Institute of Virology in Wuhan Credit: AFP 7 Covid killed millions worldwide in the pandemic It comes after The Sun's explosive Covid lab leak documentary laid bare the mounting evidence and disturbing questions surrounding the virus's emergence in Wuhan - home to China's most secretive bio-research facility. In April, the US unveiled a bombshell new Advertisement And in a fresh propaganda push, Beijing insisted "substantial evidence" showed Covid "might have emerged in the United States earlier than its officially-claimed timeline, and earlier than the outbreak in China". The document - titled Covid-19 Prevention, Control and Origins Tracing: China's Actions and Stance - was released via China's official Xinhua news agency. It unashamedly accused the US of "indifference and delayed actions" during the global Covid fight - and of scapegoating China to deflect from its own "mismanaged" response. It wrote: "The US has made China the primary scapegoat for its own mismanaged COVID-19 response." Advertisement 7 Security guards keep watch outside the Wuhan Institute of Virology The report added that America was 'spreading misinformation' and wasted 'precious time China had secured for the global fight against the pandemic". It revived Beijing's long-standing claims that it shared information with the world in a "timely manner". Advertisement The paper added: 'The US should not continue to 'pretend to be deaf and dumb', but should respond to the legitimate concerns of the international community.' Read more on the Irish Sun In May Donald Trump banned all US funding for risky virus research in China and beyond, five years after Covid-19 upended the planet. The US President said in the Oval Office last month: 'I said that right from day one it leaked out — whether it was to the girlfriend or somebody else, [a] scientist walked outside to have lunch with the girlfriend or was together with a lot of people — but that's how it leaked out in my opinion ." The Sun's investigation into the origins of Covid 'Smoking gun' docs show Pentagon US government Wuhan Covid 'lab leak' firm Covid was Crumbling sewers, no PPE, & filthy cages – Wuhan Covid 'lab leak' scientists China's Secret memo shows how Wuhan lab chief France
RTÉ News
a day ago
- RTÉ News
WHO says all Covid-19 origin theories still open, after inconclusive study
All hypotheses on how the Covid-19 pandemic began remain open, the World Health Organization said Friday, following an inconclusive four-year investigation that was hamstrung by crucial information being withheld. The global catastrophe killed an estimated 20 million people, according to the WHO, while shredding economies, crippling health systems and turning people's lives upside-down. The first cases were detected in Wuhan in China in late 2019, and understanding where the SARS-CoV-2 virus that causes Covid came from is seen as key to preventing future pandemics. However, a lengthy investigation launched by the UN's health agency said that pending further data, the origins of Covid and how it first spread would remain inconclusive. "As things stand, all hypotheses must remain on the table, including zoonotic spillover and lab leak," WHO chief Tedros Adhanom Ghebreyesus told a press conference, referring to the two main hypotheses as to how the pandemic began. Expert investigation After much delay, a WHO team of experts went to Wuhan in January 2021 to look into the origins of the virus in cooperation with their Chinese counterparts. Their March 2021 joint report concluded that the most likely hypothesis was that the virus jumped from bats to humans via an intermediate animal. They also deemed the theory that it might have escaped from Wuhan's virology laboratories "extremely unlikely". However, that investigation faced harsh criticism for lacking transparency and access, and for not evaluating the lab-leak theory seriously. The WHO launched another investigation, setting up the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) in July 2021. The report by the group of 27 experts was published on Friday. "Until further requests for information are met, or more scientific data becomes available, the origins of SARS-CoV-2 and how it entered the human population will remain inconclusive," SAGO chair Marietjie Venter said at the press conference. She added that it was "not yet clear" if the Wuhan seafood market was where the virus first spilled over into humans. As for lab leak theories, she said much of the information needed to assess this hypothesis had not been made available, so it "could not be investigated, or excluded". 'Crucial question' "Over the past five years, we have learned a lot about Covid-19 but there is one crucial question about the pandemic that we have not yet answered: how it started," Tedros Adhanom Ghebreyesus said. He said SAGO had advanced understanding of the origins of Covid-19 but much of the information needed to evaluate fully all the hypotheses had not been provided. "Despite our repeated requests, China hasn't provided hundreds of viral sequences from individuals with Covid-19 early in the pandemic, more detailed information on animals sold at markets in Wuhan, and information on work done and biosafety conditions at laboratories in Wuhan," he said. "WHO is also aware of intelligence reports performed by other governments around the world on the origins of Covid-19. We have also requested access to those reports." US President Donald Trump's administration has officially embraced the lab leak theory. Tedros said finding out how Covid-19 started was a moral imperative for the sake of those who lost their lives in the pandemic. He also said the virus was continuing to evolve, take lives and leave people suffering with post-Covid conditions, or so-called long Covid.
The Irish Sun
a day ago
- The Irish Sun
New Ozempic alternative only needs to be taken once a month and leads to ‘substantial weight loss'
A NEW weight loss jab that only needs to be taken once monthly leads to "substantial weight loss", according to early trials. Drugs like Wegovy and Advertisement 1 A new weight loss jab currently being trialled only needs to be given once a month Credit: PA But a new drug currently being trialled by pharmaceutical company Amgen can be given once a month and saw users shed up to 16 per cent of their body weight over the course of a year. This is bellow the 20 per cent weight loss than can be achieved through Mounjaro - dubbed the 'King Kong' of weight loss jabs - over 18 months. But scientists behind the new trial said the less frequent dose schedule could encourage people to stick to the treatment. The drug is called maridebart cafraglutide, or MariTide for short. Advertisement Like Wegoy, Mounjaro and Ozempic, it's a , meaning it targets the GLP-1 receptors in the brain and pancreas to reduce appetite and control blood sugar. But it also targets glucose-dependent insulinotropic polypeptide (GIP) receptors, which are also involved in managing insulin release, fat storage, metabolism, and appetite. This is part of the reason the drug needs to be administered less often. "In this phase two trial, once-monthly maridebart cafraglutide resulted in substantial weight reduction in participants with obesity with or without type 2 diabetes," they wrote in Advertisement Most read in Health Exclusive "Once-monthly therapeutics for obesity may offer sustainable treatment for persons with this highly prevalent, chronic disease. "Medication at less frequent intervals may improve adherence and reduce barriers, potentially facilitating improvements in long-term health outcomes." I went on fat jabs but the hair loss was unbelievable so I quit - I'd rather be chubby with hair than skinny and bald There were 592 people aged 18 or older enrolled in the study - 465 of them were obese, defined as having a BMI of 30 or more, or a BMI of 27 with one obesity-related complication. The remaining participants had obesity as well as type 2 diabetes. Advertisement They were randomly given monthly maridebart cafraglutide injections or a placebo for a year, at dose of 140, 280, or 420 mg . Some participants remained on a stable dose throughout, while others gradually worked up to a higher one. Participants were asked to report any side effects they experienced from the drug, such as nausea, vomiting, retching, headaches, diarrhoea and constipation Those with obesity lost 12.3 to 16.2 per cent of their body weight while taking maridebart cafraglutide over 52 weeks, compared to people taking a placebo who only lost 2.5 per cent of their weight. Advertisement As for people with diabetes and obesity, they lost 8.4 to 12.3 per cent of their body weight on the drug, compared to 1.7 per cent weight loss for placebo-takers. Almost all participants taking maridebart cafraglutide experienced at least one side-effect from the drug - mild to moderate nausea, vomiting and retching were the most frequently reported side-effects. These effects were less severe when participants gradually built up to a full dose of maridebart cafraglutide, which may be the best way to get people started on it in the future . Advertisement Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Two deaths were reported in participants who received maridebart cafraglutide, but both were investigated and deemed unrelated to the drug. A handful of people taking the drug reported gallbladder issues, which can also be an issue with other weight loss jabs. Some also experienced depression and suicidal thoughts while participating in the trial. One person taking maridebart cafraglutide and one person on the placebo drug withdrew as a result. This was a phase two clinical trial, meaning it still needs to be tested on a bigger group of participants over a longer time period. Advertisement Amgen deemed the results promising enough to progress to a phase three trial. "This phase two dose-ranging trial investigating the efficacy and safety of maridebart cafraglutide, a long-acting GLP-1 receptor agonist and GIP receptor antagonist administered once monthly or less frequently, showed substantial weight reduction and no new or unexpected safety signals, supporting advancement to phase three," researchers wrote. They estimated MariTide could lead to even more weight loss, beyond a year of use. Read more on the Irish Sun "A weight plateau was not reached at 52 weeks, with weight continuing a downward trajectory," they noted. Advertisement "Therefore, longer-term trials are needed to assess the full weight efficacy of this agent."
